XBRANE fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Xbrane Biopharma AB is a biopharmaceutical company, which engages in the development and manufacture of biosimilars. Its products include Ximluci, BIIB801, Xdivane, Xtrudane, and Xdarzane. The company was founded by Jan-Willem de Gier, Marten Hellberg, and Samuel Wagner in 2008 and is headquartered in Solna, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
XBRANE does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company